The chemical class that could be described as EG629667 Inhibitors would consist of compounds that indirectly target the function or activity of the protein EG629667 by modulating the serine C-palmitoyltransferase complex or the ceramide biosynthetic process. This class of inhibitors would encompass a range of molecules with diverse structures and properties, each interacting with different components or steps of the sphingolipid biosynthesis pathway.
Myriocin, also known as ISP-1, is a potent inhibitor of serine C-palmitoyltransferase and hence can serve as a lead compound in this category, given the predicted involvement of EG629667 in this enzymatic complex. By inhibiting the initial step in sphingolipid synthesis, chemicals like myriocin can effectively reduce the overall production of ceramides and complex sphingolipids. This reduction in substrate availability can indirectly limit the activity of proteins associated with the SPT complex, including EG629667. L-Cycloserine, a structural analog of the amino acid serine, competes with serine at the active site of the SPT enzyme. Given that serine is a substrate for SPT, the presence of cycloserine can diminish the enzyme's ability to catalyze the conversion of serine to 3-ketosphinganine, which is a precursor to ceramide. This competitive inhibition may, in turn, influence the contribution of EG629667 to the SPT complex's activity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Myriocin (ISP-1) | 35891-70-4 | sc-201397 | 10 mg | $150.00 | 8 | |
A potent inhibitor of serine C-palmitoyltransferase (SPT), likely reducing the enzymatic activity that EG629667 contributes to within the SPT complex. | ||||||
Fumonisin B1 | 116355-83-0 | sc-201395 sc-201395A | 1 mg 5 mg | $200.00 $680.00 | 18 | |
A mycotoxin that inhibits ceramide synthase, potentially leading to a decrease in ceramide biosynthesis, which could indirectly impact EG629667's activity. | ||||||
Ceranib-2 | 1402830-75-4 | sc-507503 | 10 mg | $173.00 | ||
A ceramide synthase inhibitor which could decrease ceramide biosynthesis, potentially indirectly affecting EG629667's role in the SPT complex. | ||||||
Tipifarnib | 192185-72-1 | sc-364637 | 10 mg | $720.00 | ||
A farnesyltransferase inhibitor that could affect protein prenylation and membrane associations, potentially impacting EG629667's activity within the SPT complex. | ||||||
GW4869 | 6823-69-4 | sc-218578 sc-218578A | 5 mg 25 mg | $203.00 $611.00 | 24 | |
A neutral sphingomyelinase inhibitor, which could affect sphingolipid metabolism and thereby the function of EG629667. | ||||||
C75 (racemic) | 191282-48-1 | sc-202511 sc-202511A sc-202511B | 1 mg 5 mg 10 mg | $72.00 $206.00 $290.00 | 9 | |
An inhibitor of fatty acid synthase and ceramide synthase, which may indirectly influence the ceramide biosynthesis process involving EG629667. | ||||||